×
Site Menu
Everything
International
Politics
Local
Finance
Sports
Entertainment
Lifestyle
Technology
Literature
Science
Health
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
2 months ago
70
A Biogen facility in Cambridge, Massachusetts.
Brian Snyder | Reuters
Biogen
Read Entire Article
Homepage
Finance
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Related
RFK Jr. says cyclospora outbreak is 'under control'
4 hours ago
10
Goldman Sachs creates private markets platform as rich inves...
4 hours ago
7
GM announces new gas-powered Cadillac vehicles amid EV pullb...
9 hours ago
7
RIGHT SIDEBAR TOP AD
Trending
Popular
Russian attack on Odesa kills three as Ukraine targets vesse...
6 days ago
37
Scientists finally solved how a common gut bacterium trigger...
5 days ago
35
Trump urges ICE to keep using traffic stops after deadly inc...
6 days ago
34
Ukrainian drone attacks on Russia kill at least 8, wound doz...
3 days ago
33
Anthropic moves closer to mega-IPO as bankers line up invest...
6 days ago
32
RIGHT SIDEBAR BOTTOM AD